Time to Develop and Predictors of Peripheral Intravenous Cannula-Related Local Complications Among Neonates Admitted to Neonatal Intensive Care Units in Tigray, Ethiopia: A Prospective Cohort Study

This prospective cohort study of 528 neonates in Tigray, Ethiopia, found that 41% experienced peripheral intravenous cannula-related local complications, with a median onset of 78 hours, and identified chronic illness, lack of saline flushing, non-visible veins, multiple insertion attempts, and specific insertion sites as significant independent predictors.

The Gist

Imagine a newborn baby in a hospital is like a tiny, fragile house that needs constant supplies delivered to keep the lights on and the walls strong. The "supplies" are fluids and medicine, and the "delivery trucks" are the IV lines (peripheral intravenous cannulas) stuck into their veins.

This study is essentially a report card on how well those delivery trucks are working in the neonatal wards of Tigray, Ethiopia. The researchers wanted to know two main things: How long do these trucks stay on the road before they break down? and What causes them to break down?

Here is the breakdown of their findings in everyday language:

The Big Picture: The "Leaky Hose" Problem

In the NICU (Neonatal Intensive Care Unit), babies need IVs almost all the time. But just like a garden hose, these IVs can get kinked, clogged, or leak into the surrounding soil (the baby's tissue) instead of delivering water to the roots. This is called a "complication."

The study followed 528 babies for up to 4 days (96 hours). They found that 41% of the babies experienced a problem with their IV line. That's nearly 1 in every 2 babies! When a line fails, the medical team has to stop, find a new spot, and try again, which is painful for the baby and stressful for the parents.

The Timing: It's a Race Against the Clock

The researchers used a stopwatch to see how long an IV line usually lasts before it fails.

• The Average Lifespan: The median time before a complication happened was 78 hours (about 3 days and 6 hours).
• The Trend: Think of the IV line like a sandbag holding back a flood. At first, it holds strong. But as time goes on, the risk of it failing increases. By the 3-day mark, almost half the lines had failed. By day 4, over 80% had failed.

The "Why": The Predictors (What Makes the Hose Break?)

The study identified specific "tipping points" that made the IVs fail much faster. Here are the main culprits, explained with analogies:

1. The "Chronic Sickness" Factor

• The Finding: Babies with long-term (chronic) illnesses were more likely to have IV problems than those with short-term (acute) issues.
• The Analogy: Imagine a house that is already under construction and has a shaky foundation. If you try to run a heavy delivery truck over it, it's more likely to collapse than if the house were brand new and solid. Sick babies have more fragile veins and weaker bodies, making the "delivery route" more prone to collapse.

2. The "No-Flush" Mistake

• The Finding: If the nurses didn't flush the line with saline (salt water) regularly, the risk of failure jumped by nearly double.
• The Analogy: Think of the IV line like a straw you use to drink a thick milkshake. If you don't rinse the straw with water between sips, the milkshake dries up and clogs the straw. Flushing the line keeps the "straw" clear and prevents the medicine from drying out and blocking the path.

3. The "Blind Search" (Non-Visible Veins)

• The Finding: If the nurse couldn't easily see the vein, the risk of failure doubled.
• The Analogy: Imagine trying to thread a needle in the dark. If you can't see the eye of the needle, you might poke the fabric, miss the hole, or bend the needle. When veins are hidden, nurses have to "poke and prod," which damages the delicate vein walls, causing them to swell or leak.

4. The "Retry" Penalty (Multiple Attempts)

• The Finding: If it took the nurse 3 or more tries to get the IV in, the risk of failure went up significantly.
• The Analogy: If you try to park a car in a tight spot and miss three times, you've probably scratched the paint and dented the bumper. Every time a needle misses a vein, it causes trauma to the tissue, making the next attempt harder and the line less stable.

5. The "Wrong Parking Spot" (Insertion Site)

• The Finding: Putting the IV in the leg or the elbow (cubital fossa) was much riskier than putting it in the hand or scalp.
• The Analogy:
  • Legs: Putting an IV in the leg is like parking a delivery truck on a bumpy, moving road. Babies kick their legs, and the constant movement knocks the IV loose or bends the vein.
  • Elbows: The elbow is a hinge joint. Every time the baby bends their arm, it's like folding a garden hose in half—it kinks and stops the flow.
  • Hand/Scalp: These are like parking in a flat, quiet garage. They move less, so the line stays stable longer.

The Takeaway: How to Fix the Delivery System

The authors suggest that to keep the "delivery trucks" running smoothly, hospitals need to:

1. Flush the lines: Treat the IV like a straw and rinse it regularly.
2. Pick the right spot: Stick to the hands and scalps; avoid the legs and elbows.
3. Be gentle: If a nurse can't see the vein, they should use special lights (like night-vision goggles) or ask for help rather than guessing and poking repeatedly.
4. Watch the clock: Since most lines fail around the 3-day mark, check them frequently and replace them before they break.

In short: This study tells us that while IVs are essential for saving babies, they are fragile. By treating them with more care—choosing the right spot, keeping them clean, and not forcing them—we can stop the "leaks," reduce pain for the babies, and get them home sooner.

Technical Summary

1. Problem Statement

Peripheral intravenous cannulation (PIVC) is a critical invasive procedure in neonatal intensive care units (NICUs) for administering fluids, medications, and blood products. However, it carries a high risk of local complications such as phlebitis, infiltration, extravasation, and occlusion. These complications can lead to therapy interruption, increased pain, repeated cannulation attempts, and prolonged hospital stays.

While global data exists, there is a significant evidence gap regarding the timing and predictors of PIVC complications specifically within the neonatal population in low-resource settings like Ethiopia. Previous Ethiopian studies often focused on mixed adult/pediatric populations or lacked time-to-event analysis. This study addresses the need for context-specific data to optimize catheter management and improve neonatal outcomes in the Tigray region.

2. Methodology

• Study Design: A hospital-based prospective cohort study.
• Setting: Five public general hospitals in the Tigray region, Northern Ethiopia, providing NICU services.
• Study Period: February to March 2024.
• Sample Size: 528 neonates requiring PIVC therapy.
  • Sampling: Five hospitals were selected via simple random sampling. Participants were selected using systematic random sampling (interval = 2) from the total admissions during the study period.
• Inclusion Criteria: Neonates admitted to NICU requiring PIVC, with parental informed consent.
• Exclusion Criteria: Neonates transferred from other units, those with pre-existing local PIVC complications, or those with PIVCs inserted solely for temporary diagnostic procedures.
• Follow-up: Neonates were followed for a maximum of 96 hours or until the first occurrence of a local complication, death, discharge, or transfer.
• Data Collection:
  • Structured questionnaires for socio-demographics and clinical history.
  • Observational checklists for procedural factors and complication assessment (assessed hourly).
  • Data collectors were trained BSc nurses not employed at the study hospitals to minimize bias.
• Statistical Analysis:
  • Descriptive: Median and Interquartile Range (IQR) for continuous variables; frequencies for categorical variables.
  • Survival Analysis: Kaplan-Meier estimator to determine median time to complication and cumulative failure probability. Log-rank tests compared survival curves across groups.
  • Predictive Modeling: Cox proportional hazards regression (bivariable and multivariable) to identify independent predictors.
  • Model Validation: Proportional hazards assumption tested via Schoenfeld residuals; goodness-of-fit assessed via Cox-Snell residuals. Multicollinearity checked using Variance Inflation Factor (VIF).

3. Key Results

• Incidence:

  • 41% (214/528) of neonates developed local PIVC complications.
  • Incidence Rate: 8.85 complications per 1,000 catheter-hours.
  • Median Time to Complication: 78 hours (95% CI: 67–80).
  • Cumulative Failure: By 96 hours, the cumulative failure probability reached 81%.

• Independent Predictors (Multivariable Cox Regression):
  The study identified six significant independent predictors (Adjusted Hazard Ratio - AHR) associated with a higher risk of complications:

  1. Chronic Disease Condition: AHR = 1.54 (95% CI: 1.15–2.07). Neonates with chronic illnesses failed faster than those with acute conditions.
  2. Absence of Saline Flushing: AHR = 1.83 (95% CI: 1.39–2.41). Lines not flushed with normal saline had significantly higher failure rates.
  3. Non-Visible Veins: AHR = 2.07 (95% CI: 1.55–2.76). Difficulty in visualizing veins doubled the risk.
  4. Multiple Insertion Attempts (≥3): AHR = 1.85 (95% CI: 1.15–2.98). Three or more attempts increased risk by 85% compared to a single attempt.
  5. Insertion Site (Leg): AHR = 1.84 (95% CI: 1.28–2.64). Leg insertions were less reliable than scalp or hand sites.
  6. Insertion Site (Cubital Fossa): AHR = 1.62 (95% CI: 1.10–2.39).

• Kaplan-Meier Findings:

  • Neonates with chronic conditions, non-flushed lines, non-visible veins, and those requiring multiple attempts showed steeper failure curves (earlier complications).
  • The dorsum of the hand and scalp showed the lowest failure rates compared to legs and the cubital fossa.

4. Key Contributions

• Time-to-Event Analysis: Unlike previous cross-sectional studies in the region, this study utilized survival analysis to determine the median time to complication (78 hours), providing a critical window for clinical intervention.
• Context-Specific Evidence: It fills a data void for the Tigray region, a resource-limited setting where neonatal morbidity is high and standardized care protocols may vary.
• Identification of Modifiable Factors: The study highlights specific, actionable procedural factors (flushing, insertion attempts, site selection) that healthcare providers can control to reduce complications.
• Validation of Guidelines: The findings support the recommendation for routine PIVC replacement within 72–96 hours, as the failure rate rises sharply after 72 hours.

5. Significance and Recommendations

• Clinical Practice:
  • Routine Flushing: Implement mandatory saline flushing protocols to prevent occlusion and fibrin sheath formation.
  • Site Selection: Prioritize the dorsum of the hand or scalp; avoid legs and the cubital fossa where possible.
  • Technique: Minimize insertion attempts. If veins are not visible, utilize vein visualization technologies (e.g., transillumination) rather than repeated blind punctures.
  • Monitoring: Intensify monitoring for neonates with chronic conditions and those with non-visible veins, as they are at highest risk.
• Policy & Training:
  • Continuous training for healthcare providers on PIVC insertion techniques and maintenance is essential.
  • Development of standardized local guidelines for PIVC care in Ethiopian NICUs.
• Future Research: The authors recommend multicenter longitudinal studies to validate these predictors and explore long-term outcomes, as well as the integration of vein-visualization devices to improve first-attempt success rates.

Conclusion:
PIVC-related complications in Tigray's NICUs are frequent and occur early (median 78 hours). The study provides robust evidence that modifiable procedural factors—specifically flushing, insertion attempts, and site selection—are critical determinants of catheter survival. Addressing these factors through targeted training and protocol adherence can significantly reduce neonatal morbidity and improve the quality of care.